A report by the Millennium Research Group shows that GE Healthcare was the leader in the ultrasound market for 2009 and is poised for strong growth through 2014 over Philips and Siemens.
Millennium Research Group has released a report, "U.S. Markets for
Ultrasound Systems 2010," showing GE Healthcare as the leader in the $1.2
ultrasound market in 2009, with robust growth forecasted through 2014.
The ultrasound market comprises products used for anesthesia, emergency
medicine, vascular access, surgery and critical care.
This market will have stronger gains over the next five years than
traditional radiology and cardiology ultrasound, MRG reports.
GE has focused on both of these areas, according to the firm, moving up to a
27 percent market share in emerging ultrasound for 2009, up from 10 percent in
2007, according to Isuru Silva, an analyst at MRG.
"GE is gaining share over Philips and Siemens since they have a strong
presence in the slow growth mature ultrasound markets-for example, radiology
and cardiology-and are also realizing significant growth in the fastest growing
market of emerging ultrasound," Silva wrote in an e-mail to eWEEK. "This
is in contrast to Philips and Siemens, whose strong presence is primarily
limited to the mature markets."
GE products such as LOGIQ E9 and Venue 40 have led to the market's growth,
Silva noted. He explained that they facilitate procedures for physicians such
as anesthesia and gaining vascular access.
The LOGIQ E9 has a beamformer that alters the reality of what a patient
looks like and provides uniformity of images from the near to far end, despite
varying patient body types, according to GE. In addition, a TruScan
architecture allows for the optimum flexibility with raw image data, GE
"We've long believed that GE Healthcare's ultrasound products, from the
full-featured LOGIQ E9 to the pocket-size Vscan, can be used by a wide variety
of clinicians in their practices as they turn to ultrasound technology for its
ease of use and simplicity," a GE spokesperson wrote in an e-mail to
The GE Venue 40 ultrasound line provides visual guidance on needle
procedures and rapid diagnostics at the patient's bedside in real time,
according to GE.
The Venue 40 line includes models for Vascular Access, Anesthesia,
Interventional (for biopsy guidance), Point of Care and Musculoskeletal for
monitoring rheumatoid arthritis or sports injuries to the muscle, joint or tendon.
"Systems dedicated to particular applications are growing in
popularity, as they are designed to meet the specific needs and skill set of
doctors (including those with minimal ultrasound experience) in these
particular fields," MRG's Silva wrote.
To compile the research, analysts at MRG interviewed many industry experts
in the U.S.
ultrasound market. "They aim to speak to a large percentage of the market
by market share, to gain an accurate depiction of trends in the market, and
what factors are driving and limiting the growth in each of these
markets," Silva explained.
GE, Philips and Siemens also compete in the area of computed tomography (CT)
colonography technology. A report
by the Mayo Clinic
in June found that GE's software-based medical technique
Adaptive Statistical Iterative Reconstruction, or ASIR, cuts radiation from
colonography scanners by 50 percent.